Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
Marco Cosentino, Franca Marino
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10881-10881
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 92
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 54
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
Petra Kiszel, Pál Sík, János Miklós, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 42
SARS-CoV-2 and the spike protein in endotheliopathy
Luca Perico, Ariela Benigni, Giuseppe Remuzzi
Trends in Microbiology (2023) Vol. 32, Iss. 1, pp. 53-67
Open Access | Times Cited: 36
Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2023) Vol. 11, Iss. 2, pp. 451-451
Open Access | Times Cited: 31
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects
Dimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 636-636
Open Access | Times Cited: 31
Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine
Mingyuan Li, Lin Jia, Yanbo Xie, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 24
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response
Saurav Kumar Jha, Mohammad Imran, Laxmi Akhileshwar Jha, et al.
Environmental Research (2023) Vol. 236, pp. 116823-116823
Closed Access | Times Cited: 21
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues
Panagis Polykretis, Alberto Donzelli, Janci C. Lindsay, et al.
Autoimmunity (2023) Vol. 56, Iss. 1
Open Access | Times Cited: 17
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 7
Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology
Taïeb Ach, M. El Euch
Vaccines (2022) Vol. 10, Iss. 12, pp. 2004-2004
Open Access | Times Cited: 28
Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination
Ilaria Muller, Dario Consonni, Erica Crivicich, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 2, pp. 516-526
Open Access | Times Cited: 14
The COVID-19 inflammation and high mortality mechanism trigger
Samuel Stróż, Piotr Kosiorek, Anna Stasiak‐Barmuta
Immunogenetics (2023) Vol. 76, Iss. 1, pp. 15-25
Closed Access | Times Cited: 12
Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population
Loredana Frasca, Giuseppe Ocone, Raffaella Palazzo
Pathogens (2023) Vol. 12, Iss. 2, pp. 233-233
Open Access | Times Cited: 10
Spike protein-related proteinopathies: a focus on the neurological side of spikeopathies
Andreas Posa
Annals of Anatomy - Anatomischer Anzeiger (2025), pp. 152662-152662
Open Access
Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology
Matthew Halma, Paul E. Marik, Yusuf M. Saleeby
Endocrine and Metabolic Science (2024) Vol. 14, pp. 100163-100163
Open Access | Times Cited: 3
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines
Peter Rhodes, Peter Parry
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 4, pp. 317-333
Closed Access | Times Cited: 2
The Blind Spot in COVID-19 Vaccination Policies: Under-Reported Adverse Events
Patrick Provost
International Journal of Vaccine Theory Practice and Research (2023) Vol. 3, Iss. 1, pp. 707-726
Open Access | Times Cited: 5
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
Cristiana Perrotta, Claudio Fenizia, Carla Carnovale, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1481-1481
Open Access | Times Cited: 5
Could the Spike Protein Derived from mRNA Vaccines Negatively Impact Beneficial Bacteria in the Gut?
Alberto Rubio‐Casillas, Mark Fabrowski, Carlo Brogna, et al.
(2024)
Open Access | Times Cited: 1
De novo myasthenia gravis in a patient with malignant melanoma after concurrent SARS-CoV-2 vaccination and immune checkpoint inhibitor therapy: Case report and literature review
Mohadeseh Shahin, Pedram Fadavi, Mohammad Mostafa Ansari Ramandi, et al.
eNeurologicalSci (2024) Vol. 37, pp. 100534-100534
Open Access | Times Cited: 1
The Immunologic Downsides Associated with the Powerful Translation of Current COVID-19 Vaccine mRNA Can Be Overcome by Mucosal Vaccines
Maurizio Federico
Vaccines (2024) Vol. 12, Iss. 11, pp. 1281-1281
Open Access | Times Cited: 1
In response to Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
Marco Cosentino, Franca Marino
Journal of Perinatology (2023) Vol. 43, Iss. 6, pp. 827-827
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top